FI108296B - Menetelmä terapeuttisesti aktiivisten 1,6-diatsabisyklo[3.2.1]oktaani- ja 1,4-diatsabisyklo[3.3.1]nonaanijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti aktiivisten 1,6-diatsabisyklo[3.2.1]oktaani- ja 1,4-diatsabisyklo[3.3.1]nonaanijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI108296B
FI108296B FI946140A FI946140A FI108296B FI 108296 B FI108296 B FI 108296B FI 946140 A FI946140 A FI 946140A FI 946140 A FI946140 A FI 946140A FI 108296 B FI108296 B FI 108296B
Authority
FI
Finland
Prior art keywords
formula
diazabicyclo
compounds
compound
substance
Prior art date
Application number
FI946140A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI946140A (fi
FI946140A0 (fi
Inventor
Jr Harry R Howard
Kevin D Shenk
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI946140A0 publication Critical patent/FI946140A0/fi
Publication of FI946140A publication Critical patent/FI946140A/fi
Application granted granted Critical
Publication of FI108296B publication Critical patent/FI108296B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
FI946140A 1993-12-29 1994-12-28 Menetelmä terapeuttisesti aktiivisten 1,6-diatsabisyklo[3.2.1]oktaani- ja 1,4-diatsabisyklo[3.3.1]nonaanijohdannaisten valmistamiseksi FI108296B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17503493A 1993-12-29 1993-12-29
US17503493 1993-12-29

Publications (3)

Publication Number Publication Date
FI946140A0 FI946140A0 (fi) 1994-12-28
FI946140A FI946140A (fi) 1995-06-30
FI108296B true FI108296B (fi) 2001-12-31

Family

ID=22638565

Family Applications (1)

Application Number Title Priority Date Filing Date
FI946140A FI108296B (fi) 1993-12-29 1994-12-28 Menetelmä terapeuttisesti aktiivisten 1,6-diatsabisyklo[3.2.1]oktaani- ja 1,4-diatsabisyklo[3.3.1]nonaanijohdannaisten valmistamiseksi

Country Status (26)

Country Link
US (2) US5854239A (no)
EP (1) EP0737194B1 (no)
JP (1) JP2895630B2 (no)
KR (1) KR100197454B1 (no)
CN (1) CN1046515C (no)
AT (1) ATE177099T1 (no)
AU (1) AU699465B2 (no)
BR (1) BR9408450A (no)
CA (1) CA2180263C (no)
CO (1) CO4230019A1 (no)
CZ (1) CZ282567B6 (no)
DE (1) DE69416869T2 (no)
DK (1) DK0737194T3 (no)
ES (1) ES2127946T3 (no)
FI (1) FI108296B (no)
GR (1) GR3029853T3 (no)
HU (1) HUT74682A (no)
IL (1) IL112118A (no)
NO (1) NO305600B1 (no)
NZ (1) NZ274915A (no)
PE (1) PE49395A1 (no)
PL (1) PL179435B1 (no)
RU (1) RU2124014C1 (no)
TW (1) TW369526B (no)
WO (1) WO1995018129A1 (no)
ZA (1) ZA9410339B (no)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854239A (en) * 1993-12-29 1998-12-29 Pfizer Inc. Diazabicyclic neuokinin antagonists
FR2786770B1 (fr) * 1998-12-04 2001-01-19 Synthelabo Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
WO2001095904A1 (en) * 2000-06-12 2001-12-20 University Of Rochester Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist
FR2812635B1 (fr) * 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
SE0003795D0 (sv) 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
FR2825705B1 (fr) * 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
FR2835186B1 (fr) * 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
FR2844273B1 (fr) 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
US7439253B2 (en) 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
FR2848210B1 (fr) * 2002-12-06 2007-10-19 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases
KR101412339B1 (ko) 2004-07-15 2014-06-25 알바니 몰레큘라 리써치, 인크. 아릴- 및 헤테로아릴-치환된 테트라히드로이소퀴놀린, 및이것의 노르에피네프린, 도파민 및 세로토닌의 재흡수를차단하기 위한 용도
US8362075B2 (en) 2005-05-17 2013-01-29 Merck Sharp & Dohme Corp. Cyclohexyl sulphones for treatment of cancer
WO2006135783A2 (en) * 2005-06-10 2006-12-21 Wisconsin Alumni Research Foundation Compositions and methods for modulating angiogenesis
NZ565111A (en) 2005-07-15 2011-10-28 Amr Technology Inc Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
WO2007041052A2 (en) 2005-09-29 2007-04-12 Merck & Co., Inc. Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
GB0603041D0 (en) 2006-02-15 2006-03-29 Angeletti P Ist Richerche Bio Therapeutic compounds
WO2008039327A2 (en) 2006-09-22 2008-04-03 Merck & Co., Inc. Method of treatment using fatty acid synthesis inhibitors
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
TWI454262B (zh) * 2006-11-02 2014-10-01 Targacept Inc 菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺
WO2008084261A1 (en) 2007-01-10 2008-07-17 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
US8106086B2 (en) 2007-04-02 2012-01-31 Msd K.K. Indoledione derivative
EP2170076B1 (en) 2007-06-27 2016-05-18 Merck Sharp & Dohme Corp. 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
RS53862B1 (en) 2008-01-18 2015-08-31 Merck Sharp & Dohme Corp. INHIBITOR BETA-LACTAMASE
CA2717509A1 (en) 2008-03-03 2009-09-11 Tiger Pharmatech Tyrosine kinase inhibitors
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
WO2010114780A1 (en) 2009-04-01 2010-10-07 Merck Sharp & Dohme Corp. Inhibitors of akt activity
WO2010132487A1 (en) 2009-05-12 2010-11-18 Bristol-Myers Squibb Company CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
CN102595902B (zh) 2009-05-12 2015-04-29 阿尔巴尼分子研究公司 7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉及其用途
ES2446971T3 (es) 2009-05-12 2014-03-11 Albany Molecular Research, Inc. Tetrahidroisoquinolinas sustituidas con arilo, heteroarilo, y heterociclo y su uso
FR2951171A1 (fr) * 2009-10-09 2011-04-15 Novexel Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
NZ599343A (en) 2009-10-14 2014-05-30 Merck Sharp & Dohme Substituted piperidines that increase p53 activity and the uses thereof
WO2011163330A1 (en) 2010-06-24 2011-12-29 Merck Sharp & Dohme Corp. Novel heterocyclic compounds as erk inhibitors
US8518907B2 (en) 2010-08-02 2013-08-27 Merck Sharp & Dohme Corp. RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)
RU2624045C2 (ru) 2010-08-17 2017-06-30 Сирна Терапьютикс,Инк ОПОСРЕДУЕМОЕ РНК-ИНТЕРФЕРЕНЦИЕЙ ИНГИБИРОВАНИЕ ЭКСПРЕССИИ ГЕНОВ ВИРУСА ГЕПАТИТА B (HBV) С ПРИМЕНЕНИЕМ МАЛОЙ ИНТЕРФЕРИРУЮЩЕЙ НУКЛЕИНОВОЙ КИСЛОТЫ (миНК)
EP2608669B1 (en) 2010-08-23 2016-06-22 Merck Sharp & Dohme Corp. NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
WO2012030685A2 (en) 2010-09-01 2012-03-08 Schering Corporation Indazole derivatives useful as erk inhibitors
WO2012036997A1 (en) 2010-09-16 2012-03-22 Schering Corporation Fused pyrazole derivatives as novel erk inhibitors
WO2012058210A1 (en) 2010-10-29 2012-05-03 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA)
EP2654748B1 (en) 2010-12-21 2016-07-27 Merck Sharp & Dohme Corp. Indazole derivatives useful as erk inhibitors
CA2822758C (en) * 2010-12-22 2018-03-20 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivative and process for preparing the same
US20140045832A1 (en) 2011-04-21 2014-02-13 Piramal Enterprises Limited Insulin-Like Growth Factor-1 Receptor Inhibitors
MX348974B (es) * 2011-08-27 2017-07-04 Wockhardt Ltd Derivados 1,6 - diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
RU2570423C2 (ru) * 2011-08-30 2015-12-10 Вокхардт Лимитед Производные 1,6-диазабицикло[3.2.1]октан-7-она и их применение при лечении бактериальных инфекций
BR112014003476A2 (pt) * 2011-09-13 2017-03-01 Wockhardt Ltd compostos contendo nitrogênio e seu uso
WO2013063214A1 (en) 2011-10-27 2013-05-02 Merck Sharp & Dohme Corp. Novel compounds that are erk inhibitors
AR090539A1 (es) * 2012-04-02 2014-11-19 Astrazeneca Ab COMPUESTOS INHIBIDORES DE b LACTAMASA
EP3358013B1 (en) 2012-05-02 2020-06-24 Sirna Therapeutics, Inc. Short interfering nucleic acid (sina) compositions
BR112014029368B1 (pt) * 2012-05-30 2020-10-27 Meiji Seika Pharma Co., Ltd inibidor de beta-lactamase e processo para preparar o mesmo
US9233979B2 (en) 2012-09-28 2016-01-12 Merck Sharp & Dohme Corp. Compounds that are ERK inhibitors
EP3610890A1 (en) 2012-11-14 2020-02-19 The Johns Hopkins University Methods and compositions for treating schizophrenia
PT2925888T (pt) 2012-11-28 2017-12-13 Merck Sharp & Dohme Composições e métodos para tratamento do cancro
CA2895504A1 (en) 2012-12-20 2014-06-26 Merck Sharp & Dohme Corp. Substituted imidazopyridines as hdm2 inhibitors
WO2014120748A1 (en) 2013-01-30 2014-08-07 Merck Sharp & Dohme Corp. 2,6,7,8 substituted purines as hdm2 inhibitors
JP6285969B2 (ja) * 2013-03-08 2018-02-28 ウォックハート リミテッド （２ｓ，５ｒ）−７−オキソ−６−スルホオキシ−２−［（（３ｒ）−ピペリジン−３−カルボニル）−ヒドラジノカルボニル］−１，６−ジアザ−ビシクロ［３．２．１］オクタンの調製のためのプロセス
RU2627698C2 (ru) * 2013-03-08 2017-08-10 Вокхардт Лимитед Натриевая соль (2s, 5r)-6-бензилокси-7-оксо-1,6-диаза-бицикло[3.2.1]октан-2-карбоновой кислоты и ее получение
AU2013380575B2 (en) * 2013-03-08 2016-07-07 Wockhardt Limited A process for preparation of (2S, 5R)-7-oxo-6-sulphooxy-2-[((3R)-pyrrolidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo[3.2.1]octane
RU2621051C2 (ru) * 2013-03-08 2017-05-31 Вокхардт Лимитед Способ получения (2s, 5r)-моно-{ [(4-аминопиперидин-4-ил)карбонил]-7-оксо-1, 6-диазабицикло[3.2.1]окт-6-ил} ового сложного эфира серной кислоты
US20160194368A1 (en) 2013-09-03 2016-07-07 Moderna Therapeutics, Inc. Circular polynucleotides
MY176278A (en) * 2013-09-24 2020-07-27 Meiji Seika Pharma Co Ltd Process for producing diazabicyclooctane derivative and intermediate thereof
HUE044061T2 (hu) 2014-11-17 2019-09-30 Entasis Therapeutics Ltd Kombinációs terápia rezisztens bakteriális fertõzések kezelésére
MX2017012545A (es) 2015-04-03 2018-09-28 Mutabilis Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
PL3512851T3 (pl) 2016-09-16 2022-11-14 Entasis Therapeutics Limited Związki stanowiące inhibitory beta-laktamazy
EA038393B1 (ru) 2017-05-08 2021-08-20 Энтасис Терапеутикс, Инк. Соединения и способы для лечения бактериальных инфекций
US10947234B2 (en) 2017-11-08 2021-03-16 Merck Sharp & Dohme Corp. PRMT5 inhibitors
CN108610313B (zh) * 2018-06-08 2022-03-04 三峡大学 一种酶抑制剂及其应用
WO2020033282A1 (en) 2018-08-07 2020-02-13 Merck Sharp & Dohme Corp. Prmt5 inhibitors
EP3833667B1 (en) 2018-08-07 2024-03-13 Merck Sharp & Dohme LLC Prmt5 inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3494923A (en) * 1965-05-28 1970-02-10 Sterling Drug Inc 1,2,3,4,5,8-hexahydro-1,5-methanobenzo (f)(1,4)diazocine
DE69200921T2 (de) * 1991-03-01 1995-05-04 Pfizer 1-azabicyclo[3.2.2]nonan-3-aminderivate.
US5854239A (en) * 1993-12-29 1998-12-29 Pfizer Inc. Diazabicyclic neuokinin antagonists

Also Published As

Publication number Publication date
HUT74682A (en) 1997-01-28
CA2180263C (en) 2000-05-16
IL112118A (en) 1998-10-30
BR9408450A (pt) 1997-08-05
ZA9410339B (en) 1996-06-28
IL112118A0 (en) 1995-03-15
KR100197454B1 (ko) 1999-06-15
ATE177099T1 (de) 1999-03-15
PL179435B1 (pl) 2000-09-29
US5854239A (en) 1998-12-29
WO1995018129A1 (en) 1995-07-06
PE49395A1 (es) 1996-01-06
CZ188696A3 (en) 1996-10-16
EP0737194B1 (en) 1999-03-03
PL315193A1 (en) 1996-10-14
CO4230019A1 (es) 1995-10-19
DE69416869D1 (de) 1999-04-08
EP0737194A1 (en) 1996-10-16
JPH09500904A (ja) 1997-01-28
US6110919A (en) 2000-08-29
AU699465B2 (en) 1998-12-03
NZ274915A (en) 1997-11-24
GR3029853T3 (en) 1999-07-30
NO962742D0 (no) 1996-06-28
ES2127946T3 (es) 1999-05-01
NO305600B1 (no) 1999-06-28
HU9601790D0 (en) 1996-09-30
AU8002194A (en) 1995-07-17
DK0737194T3 (da) 1999-09-27
NO962742L (no) 1996-06-28
FI946140A (fi) 1995-06-30
FI946140A0 (fi) 1994-12-28
JP2895630B2 (ja) 1999-05-24
CN1139434A (zh) 1997-01-01
CN1046515C (zh) 1999-11-17
DE69416869T2 (de) 1999-07-01
CZ282567B6 (cs) 1997-08-13
RU2124014C1 (ru) 1998-12-27
TW369526B (en) 1999-09-11

Similar Documents

Publication Publication Date Title
FI108296B (fi) Menetelmä terapeuttisesti aktiivisten 1,6-diatsabisyklo[3.2.1]oktaani- ja 1,4-diatsabisyklo[3.3.1]nonaanijohdannaisten valmistamiseksi
FI113654B (fi) Menetelmä terapeuttisesti käyttökelpoisten atsabisyklo[2.2.2]oktaani-3-amiinien valmistamiseksi
EP0675886B1 (en) Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
FI108794B (fi) Menetelmä terapeuttisesti käyttökelpoisten fluorialkoksiaryylisubstituoitujen metyyliaminokinuklidiiniyhdisteiden valmistamiseksi
US5688806A (en) Spiroazacyclic derivatives as substance P antagonists
US5741797A (en) Heteroatom substituted alkyl benzylaminoquinuclidines
US5929094A (en) Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists
PT862567E (pt) 5-azabiciclo(3.1.0)hexilalquil-2-piperidonas e -glutarimidas como antagonistas do receptor de neurocinina
SK15612002A3 (sk) Azabicyklické karbamáty, spôsob ich prípravy a farmaceutické prostriedky, ktoré ich obsahujú ako účinné látky
JP2018526399A (ja) ヒトキチナーゼ阻害剤として有用な置換アミノトリアゾール
EP0573522A1 (en) 1-Azabicyclo [3.2.2.] Nonan-3-amine derivatives.
IE65000B1 (en) Quinuclidine derivatives
EP0708771A1 (en) Benzyloxyquinuclidines as substance p antagonists
CZ20012151A3 (cs) Chinolinové deriváty
AU2481292A (en) Fused tricyclic nitrogen containing heterocycles as substance p receptor antagonists
IE921987A1 (en) Azanorbornane derivatives
HUT76928A (hu) Amino-metil-fenil-imidazol-származékok alkalmazása emlékezetjavító gyógyászati készítmények előállítására
JP2004526788A (ja) 疾患治療用の置換型アザ二環式基（ニコチン性アセチルコリン受容体アンタゴニスト）
US20030232853A1 (en) Azabicyclic compounds for the treatment of disease
US6849620B2 (en) N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
JP2008517010A (ja) ハロゲン置換ベンゾジアゼピン誘導体
JP2010523495A (ja) サブタイプ選択的アザビシクロアルカン誘導体
WO1998017276A1 (en) Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists
JPS6396187A (ja) インドローピラジノーベンゾジアゼピン誘導体
BG106162A (bg) Трициклени аналгетици

Legal Events

Date Code Title Description
MA Patent expired